133 related articles for article (PubMed ID: 27571457)
1. Apelin Compared With Dobutamine Exerts Cardioprotection and Extends Survival in a Rat Model of Endotoxin-Induced Myocardial Dysfunction.
Chagnon F; Coquerel D; Salvail D; Marsault E; Dumaine R; Auger-Messier M; Sarret P; Lesur O
Crit Care Med; 2017 Apr; 45(4):e391-e398. PubMed ID: 27571457
[TBL] [Abstract][Full Text] [Related]
2. ELABELA Improves Cardio-Renal Outcome in Fatal Experimental Septic Shock.
Coquerel D; Chagnon F; Sainsily X; Dumont L; Murza A; Côté J; Dumaine R; Sarret P; Marsault É; Salvail D; Auger-Messier M; Lesur O
Crit Care Med; 2017 Nov; 45(11):e1139-e1148. PubMed ID: 28777197
[TBL] [Abstract][Full Text] [Related]
3. Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
Cunha-Goncalves D; Perez-de-Sa V; Larsson A; Thörne J; Blomquist S
Anesth Analg; 2009 Nov; 109(5):1576-83. PubMed ID: 19713252
[TBL] [Abstract][Full Text] [Related]
4. Resuscitation fluids and endotoxin-induced myocardial dysfunction: is selection a load-independent differential issue?
Hogue B; Chagnon F; Lesur O
Shock; 2012 Aug; 38(3):307-13. PubMed ID: 22777110
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure.
Koguchi W; Kobayashi N; Takeshima H; Ishikawa M; Sugiyama F; Ishimitsu T
Circ J; 2012; 76(1):137-44. PubMed ID: 22082814
[TBL] [Abstract][Full Text] [Related]
7. The Long-term Effect of Dobutamine on Intrinsic Myocardial Function and Myocardial Injury in Septic Rats with Myocardial Dysfunction.
Tang X; Xu Y; Dai X; Xing Y; Yang D; Huang Q; Li H; Lv X; Wang Y; Lu D; Wang H
Shock; 2021 Oct; 56(4):582-592. PubMed ID: 34524268
[TBL] [Abstract][Full Text] [Related]
8. Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction.
Azizi Y; Faghihi M; Imani A; Roghani M; Nazari A
Peptides; 2013 Aug; 46():76-82. PubMed ID: 23727032
[TBL] [Abstract][Full Text] [Related]
9. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition.
Ramana KV; Willis MS; White MD; Horton JW; DiMaio JM; Srivastava D; Bhatnagar A; Srivastava SK
Circulation; 2006 Oct; 114(17):1838-46. PubMed ID: 17030682
[TBL] [Abstract][Full Text] [Related]
11. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
13. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
[TBL] [Abstract][Full Text] [Related]
14. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
Bakkehaug JP; Naesheim T; Torgersen Engstad E; Kildal AB; Myrmel T; How OJ
Acta Physiol (Oxf); 2016 Oct; 218(2):78-88. PubMed ID: 27145482
[TBL] [Abstract][Full Text] [Related]
15. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.
Simpkin JC; Yellon DM; Davidson SM; Lim SY; Wynne AM; Smith CC
Basic Res Cardiol; 2007 Nov; 102(6):518-28. PubMed ID: 17694254
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic effects of levosimendan following cardiac surgery].
Alvarez J; Taboada M; Rodríguez J; Caruezo V; Bouzada M; Campaña O; Bascuas B; Pérez-Paz J; Ginesta V
Rev Esp Anestesiol Reanim; 2005; 52(7):389-94. PubMed ID: 16200918
[TBL] [Abstract][Full Text] [Related]
17. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
[TBL] [Abstract][Full Text] [Related]
19. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair / replacement for severe mitral stenosis.
Gandham R; Syamasundar A; Ravulapalli H; Karthekeyan RB; Vakamudi M; Kodalli R; Nandipati S
Ann Card Anaesth; 2013; 16(1):11-5. PubMed ID: 23287080
[TBL] [Abstract][Full Text] [Related]
20. The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo.
Chin KY; Michel L; Qin CX; Cao N; Woodman OL; Ritchie RH
Pharmacol Res; 2016 Feb; 104():165-75. PubMed ID: 26747404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
